Substance
EZETIMIBE
Global reference: every product and company linked to this substance.
- cas: 163222-33-1
- ncit: C47529
- pubchem_cid: 150311
- rxnorm: 341248
- unii: EOR26LQQ24
Ezetimibe [INN] · Ezetimibe [JAN] · Ezetimibe [USAN] · Ezetimibe [WHO-DD] · Ezetrol · MK0653 · NEXLIZET COMPONENT EZETIMIBE · NSC-758923 · ROSZET COMPONENT EZETIMIBE · SCH-58235 · SCH58235 · VYTORIN COMPONENT EZETIMIBE
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ORGANON & CO. COMMON STOCK | ZETIA | Q2 2026 | $96.0M |
| ORGANON & CO. COMMON STOCK | VYTORIN | Q2 2026 | $21.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (5)
- EZETIMIBE · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
- EZETIMIBE AND SIMVASTATIN · ANI PHARMACEUTICALS INC.
- LIPTRUZET · ORGANON & CO. COMMON STOCK
- VYTORIN · ORGANON & CO. COMMON STOCK
- ZETIA · ORGANON & CO. COMMON STOCK